Trade Setup Buy Price: $4.24 Sell Price: $5.16 Amyris, Inc., a biotechnology company, develops technology that creates microbial strains to produce artemisinic acid, a precursor of artemisinin, an anti-malarial drug. The company’s technology platform enables to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. It applies […]
Read MoreTrade Setup Buy Target $20.31 Sell Target $23.91 Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreTrade Setup Buy Target $56.73 Sell Target $69.14 AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Locum Tenens Solutions, and Other Workforce Solutions.
Read MoreThese 2 stocks look like they’re headed for more upside.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreStarting into a new month, a lot of analysts right now seem to be turning more optimistic. The last two months have seen a rally in the broad market indices that has a lot of people starting to talk about how much of the February-to-March drop to bear market conditions stocks have reclaimed. How much […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreIn the early stages of the arrival and spread of COVID-19 in the United States, I wrote in this space about my belief that one of the best places a smart investor should focus their attention is on healthcare stocks, including companies in the pharmacy space. News media, economists and medical professionals have all turned […]
Read MoreTrade Setup Buy Target $4.31 Sell Target $5.36 Vaccinex, Inc., a clinical-stage biotechnology company, discovers and develops bio therapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab that is in clinical development […]
Read MoreTrade Setup Buy Target $7.32 Sell Target $9.63 Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis.
Read MoreTrade Setup Buy Target $0.78 Sell Target $0.98 Castlight Health, Inc. provides health navigation solutions for employers and health plan customers in education, manufacturing, retail, technology, and government industries in the United States. It provides Care Guidance Navigator that enables users to make care decisions and navigate the employer-sponsored healthcare benefit programs
Read MoreTrade Setup Buy Target $9.65 Sell Target $13.18 Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe […]
Read MoreThe healthcare sector is on the rise and these 3 stocks in the group look like good best now.
Read MoreTrade Setup Buy Target $2.26 Sell Target $2.97 Clearside Biomedical, Inc., a late-stage clinical biopharmaceutical company, develops pharmacological therapies to restore and preserve vision for people with serious eye diseases. It develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated […]
Read More